Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Stryker Corporation
  6. Summary
    SYK   US8636671013

STRYKER CORPORATION

(SYK)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
249.54(c) 249.74(c) 253.13(c) 256.66(c) 255.79(c) Last
1 178 617 975 509 924 992 924 135 724 586 Volume
-0.91% +0.08% +1.36% +1.39% -0.34% Change
More quotes
Financials (USD)
Sales 2021 17 142 M - -
Net income 2021 2 513 M - -
Net Debt 2021 9 315 M - -
P/E ratio 2021 38,3x
Yield 2021 0,96%
Sales 2022 18 404 M - -
Net income 2022 3 261 M - -
Net Debt 2022 7 166 M - -
P/E ratio 2022 29,6x
Yield 2022 1,06%
Capitalization 96 368 M 96 368 M -
EV / Sales 2021 6,17x
EV / Sales 2022 5,63x
Nbr of Employees 43 000
Free-Float 92,7%
More Financials
Company
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. Its segments include Orthopaedics, MedSurg, Neurotechnology and Spine. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical... 
Read more
More about the company
Ratings of Stryker Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about STRYKER CORPORATION
06/07J&J vaccine drive stalls out in U.S after safety pause
RE
06/04OSHKOSH  : Unit Wins $942.9 Million Contract to Upgrade Weapon System on US Army..
MT
06/01STRYKER  : Evercore ISI Upgrades Stryker to Outperform From In-Line; Price Targe..
MT
05/25STRYKER  : Barclays Starts Stryker at Underweight with $280 Price Target
MT
05/12INSIDER TRENDS : Huntsman Corp Insider Converts Option/Derivative Security Sells..
MT
05/11STRYKER CORP  : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/05STRYKER  : SYK) sees Significant Insider Selling Continuing
MT
05/04INSIDER TRENDS : Stryker Corp Insider Converts Option/Derivative Security Sells ..
MT
05/04INSIDER TRENDS : 90-Days of Insider Buying at Stryker Corp Eased Back with Share..
MT
05/04STRYKER  : declares a $0.63 per share quarterly dividend
AQ
04/28STRYKER  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
04/28STRYKER  : Truist Securities Adjusts Stryker's Price Target to $255 From $245, M..
MT
04/28STRYKER  : Morgan Stanley Adjusts Stryker's Price Target to $280 From $265, Main..
MT
04/28STRYKER  : Deutsche Bank Adjusts Stryker's Price Target to $285 From $251, Maint..
MT
04/28STRYKER  : JPMorgan Adjusts Stryker's Price Target to $287 From $265, Maintains ..
MT
More news
News in other languages on STRYKER CORPORATION
04/27TAGESVORSCHAU : Termine am 27. April 2021
03/01Warnstreiks in norddeutscher Metall- und Elektroindustrie angelaufen
02/17LOCKHEED MARTIN  : choisi pour la protection des blindés US
2020Morning Briefing - International Teil 1
2020TAGESVORSCHAU : Termine am 29. Oktober 2020
More news
Analyst Recommendations on STRYKER CORPORATION
More recommendations
Chart STRYKER CORPORATION
Duration : Period :
Stryker Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRYKER CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 31
Average target price 271,24 $
Last Close Price 255,79 $
Spread / Highest target 18,5%
Spread / Average Target 6,04%
Spread / Lowest Target -25,7%
EPS Revisions
Managers and Directors
NameTitle
Kevin A. Lobo Chairman & Chief Executive Officer
Timothy J. Scannell President & Chief Operating Officer
Glenn S. Boehnlein Chief Financial Officer & Vice President
Alan Douville Chief Information Officer & Vice President
Dana S. McMahon Chief Compliance Officer & Vice President
Sector and Competitors
1st jan.Capitalization (M$)
STRYKER CORPORATION4.39%96 368
SMITH & NEPHEW PLC2.38%19 144
INSPIRE MEDICAL SYSTEMS, INC.-2.65%4 983
VENUS MEDTECH (HANGZHOU) INC.-8.79%4 097
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.40.14%3 960
GLAUKOS CORPORATION6.18%3 696